Medical multi-layer product comprising nanofibrillar cellulose and method for preparing thereof

US11511015B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11511015-B2
Application numberUS-201616065233-A
CountryUS
Kind codeB2
Filing dateDec 30, 2016
Priority dateDec 31, 2015
Publication dateNov 29, 2022
Grant dateNov 29, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present application provides a medical multi-layer product comprising a layer comprising nanofibrillar cellulose, and a layer of gauze. The present application also provides a medical product comprising the medical multi-layer product, and a cosmetic product comprising the medical multi-layer product. The present application also provides a method for preparing a medical multi-layer product, the method comprising providing a filter, providing a dispersion comprising nanofibrillar cellulose, providing a gauze, applying the dispersion onto the filter, applying the gauze onto the dispersion, and dewatering the structure through the filter to obtain the medical multi-layer product.

First claim

Opening claim text (preview).

The invention claimed is: 1. A medical multi-layer product comprising a first layer comprising plant nanofibrillar cellulose having a moisture content in the range of 0-10% (w/w), and a layer of gauze; wherein the product has a tear index in the range of 18-100 mNm 2 /q. 2. The medical multi-layer product of claim 1 , wherein the first layer comprising plant nanofibrillar cellulose has a moisture content in the range of 5-7% (w/w). 3. The medical multi-layer product of claim 1 , comprising a second layer comprising nanofibrillar cellulose. 4. The medical multi-layer product of claim 3 , wherein the plant nanofibrillar cellulose in the first layer and/or in the second layer, when dispersed in water, provides a Brookfield viscosity of at least 2000 mPa·s, measured at a consistency of 0.8% (w/w) and at 10 rpm. 5. The medical multi-layer product of claim 1 , wherein the gauze comprises natural gauze. 6. The medical multi-layer product of claim 1 , wherein the gauze comprises synthetic gauze or semi-synthetic. 7. The medical multi-layer product of claim 1 , wherein the plant nanofibrillar cellulose comprises non-modified nanofibrillar cellulose. 8. The medical multi-layer product of claim 1 , wherein the plant nanofibrillar cellulose comprises chemically modified plant nanofibrillar cellulose. 9. The medical multi-layer product of claim 1 , wherein a layer of plant nanofibrillar cellulose has a thickness in the range of 5-60 μm. 10. The medical multi-layer product of claim 1 , having a thickness in the range of 100-500 μm. 11. The medical multi-layer product of claim 1 , wherein the first layer comprising t nanofibrillar cellulose comprises an amount of non-nanofibrillar pulp in the range of 0.1-60% (w/w) of total cellulose in said layer. 12. The medical multi-layer product of claim 1 , wherein product has a grammage in the range of 50-100 g/m 2 . 13. The medical multi-layer product of claim 1 wherein the product has a density in the range of 300-800 kg/m 3 . 14. The medical multi-layer product of claim 1 , wherein the plant nanofibrillar cellulose in the first layer has a number average diameter of a fibril in the range of 1-100 nanometers. 15. The medical multi-layer product of claim 1 comprising a therapeutic agent. 16. The medical multi-layer product of claim 1 comprising a cosmetic agent. 17. A medical product comprising the medical multi-layer product of claim 1 . 18. A method for treating skin wounds or other damages or injuries, the method comprising applying the medical multi-layer product of claim 1 onto the wound, damage, or injury. 19. A method for treating skin wounds covered with a graft the method comprising applying the medical multi-layer product of claim 1 onto the graft. 20. A method for administering therapeutic agent, the method comprising applying the medical multi-layer product of claim 15 onto skin. 21. A method for preparing a medical multi-layer product, the method comprising providing a filter, providing a dispersion comprising plant nanofibrillar cellulose, providing a gauze, applying the dispersion onto the filter, applying the gauze onto the dispersion to form a structure, and dewatering the structure through the filter to obtain the medical multi-layer product comprising a first layer comprising plant nanofibrillar cellulose having a moisture content in the range of 0-10% (w/w). 22. The method of claim 21 , further comprising providing a second dispersion comprising nanofibrillar cellulose and applying the second dispersion comprising nanofibrillar cellulose onto the gauze. 23. A medical multi-layer product comprising a first layer comprising plant nanofibrillar cellulose having a moisture content in the range of 0-10% (w/w), and a layer of gauze; wherein the product has a tear index in the range of 18-100 mNm 2 /g, and wherein the product is obtained with the method of claim 21 . 24. A method for preparing a medical multi-layer product, the method comprising providing a first layer comprising plant nanofibrillar cellulose having a moisture content in the range of 0-10% (w/w), providing a layer of gauze, and laminating the first layer comprising plant nanofibrillar cellulose and the layer of gauze to obtain the medical multi-layer product; wherein the product has a tear index in the range of 18-100 mNm 2 /q. 25. The method of claim 24 , wherein the first layer comprising plant nanofibrillar cellulose has a moisture content in the range of 1-10%. 26. The method of claim 24 , wherein the gauze comprises natural gauze. 27. The method of claim 24 , wherein the gauze comprises synthetic gauze or semi-synthetic. 28. The method of claim 24 , wherein the plant nanofibrillar cellulose in the first layer comprising plant nanofibrillar cellulose when dispersed in water, provides a Brookfield viscosity of at least 2000 mPa·s, measured at a consistency of 0.8% (w/w) and at 10 rpm. 29. The method of claim 24 , wherein the first layer comprising plant nanofibrillar cellulose comprises non-modified plant nanofibrillar cellulose. 30. The method of claim 24 , wherein the first layer comprising plant nanofibrillar cellulose comprises chemically modified plant nanofibrillar cellulose. 31. The method of claim 24 , wherein the first layer comprising plant nanofibrillar cellulose comprises an amount of non-nanofibrillar pulp in the range of 0.1-60% (w/w) of total cellulose in said layer. 32. The method of claim 24 , comprising providing a therapeutic agent and including the therapeutic agent to the first layer comprising plant nanofibrillar cellulose. 33. The method of claim 24 , comprising providing a cosmetic agent and including the cosmetic agent to the first layer comprising plant nanofibrillar cellulose.

Assignees

Inventors

Classifications

  • Liquid-swellable gel-forming materials, e.g. super-absorbents · CPC title

  • Materials for use in artificial skin · CPC title

  • Polysaccharides · CPC title

  • Apparatus or processes for manufacturing non-adhesive dressings or bandages · CPC title

  • A61L15/28Primary

    Polysaccharides or their derivatives {(A61L15/225 takes precedence)} · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11511015B2 cover?
The present application provides a medical multi-layer product comprising a layer comprising nanofibrillar cellulose, and a layer of gauze. The present application also provides a medical product comprising the medical multi-layer product, and a cosmetic product comprising the medical multi-layer product. The present application also provides a method for preparing a medical multi-layer product…
Who is the assignee on this patent?
Upm Kymmene Corp
What technology area does this patent fall under?
Primary CPC classification A61L15/28. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Nov 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).